Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LIDOCAINE B. BRAUN 20 mg/ml injectable solution

Contents of the leaflet

  1. Introduction
  2. What is Lidocaine B. Braun and what is it used for
  3. What you need to know before you use Lidocaine B. Braun
  4. How to use Lidocaine B. Braun
  5. Possible side effects
  6. Storage of Lidocaine B. Braun
  7. Contents of the pack and other information
  8. Dosage and Administration
  9. Administration
  10. Interactions with Other Medicinal Products and Other Forms of Interaction

Introduction

Package Leaflet: Information for the Patient

Lidocaine B. Braun 20 mg/ml Solution for Injection

Lidocaine Hydrochloride

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Lidocaine B. Braun and what is it used for
  2. What you need to know before you use Lidocaine B. Braun
  3. How to use Lidocaine B. Braun
  4. Possible side effects
  5. Storage of Lidocaine B. Braun
  6. Contents of the pack and other information

1. What is Lidocaine B. Braun and what is it used for

This medicine contains lidocaine hydrochloride and belongs to a group of medicines called local anesthetics of the amide type. It is used to block pain by reducing the conduction of nerve impulses near its site of action.

Lidocaine also belongs to a group of medicines called antiarrhythmics, so it can also be used to control a rapid or abnormal heartbeat (severe ventricular arrhythmias).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Lidocaine B. Braun

Do not useLidocaine B. Braunif:

  • You are allergic to lidocaine, other local anesthetics of the amide type, or any of the other ingredients of this medicine (listed in section 6).
  • For epidural anesthesia in patients with pronounced hypotension (very low blood pressure) or cardiogenic shock (the heart pumps blood inadequately) or hypovolemic shock.

Epidural anesthesia should not be used during labor.

It should not be used to control rapid or abnormal heartbeats if:

  • You have severe heart disorders, particularly when your heart beats irregularly or slowly,
  • You have had a heart attack in the last 3 months or if your heart's ability to pump blood to the whole body is significantly reduced, unless your condition is potentially life-threatening.

Warnings and precautions:

Consult your doctor, pharmacist, or nurse before starting to use Lidocaine B. Braun.

  • If you are elderly or in a debilitated general state,
  • If you have heart problems such as a slow or irregular heartbeat or heart failure,
  • If you have any lung or respiratory disorder,
  • If you have any liver or kidney disease,
  • If you have a history of epileptic seizures,
  • If you have inflammation or infection at the injection site,
  • If you have porphyria (a rare inherited disease that affects the skin and nervous system),
  • If you have blood coagulation problems,
  • If you are in the last trimester of pregnancy.
  • A specific facial nerve disorder (Melkersson-Rosenthal syndrome),
  • If you have low blood pressure or low blood volume,
  • If you have severe muscle weakness (myasthenia gravis).

Control of rapid or abnormal heartbeats

Your doctor will administer this medicine to treat heart problems only with special caution if you have high blood acidity (acidosis).

If you receive this medicine, your:

  • electrocardiogram,
  • blood pressure,
  • level of consciousness, and
  • breathing will be monitored.

If any of the mentioned parameters worsen, your doctor may need to review your therapy. Additionally, they will ensure that the usual emergency equipment is available during therapy.

If you receive this medicine over a prolonged period, your doctor will ensure that:

  • your fluid balance,
  • blood salt levels, and
  • your acid-base balance are monitored.

If you receive large amounts of this medicine, your doctor will correct:

  • any existing low potassium level in your blood,
  • oxygen deficiency, and
  • acid-base balance disorders before starting the infusion/injection.

Note:

If you are under anesthesia, your doctor will examine your condition with great care. This will be done because side effects that affect your nervous system and heart can go unnoticed and can occur without previous warning symptoms.

Children

The use of lidocaine is not recommended in children under 1 year of age. In children under 4 years, it should be used with caution as the data on efficacy and safety are limited.

Using Lidocaine B. Braun with other medicines:

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

In particular, tell your doctor if you are taking any of the following medicines:

  • other local anesthetics.
  • medicines used to treat stomach ulcers (e.g., cimetidine).
  • medicines used to treat irregular heartbeat (e.g., amiodarone)

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Your doctor will only administer this medicine during your pregnancy or breastfeeding if they consider it necessary.

Driving and using machines

Lidocaine B. Braun may temporarily affect your ability to move, attention, and coordination. Your doctor will tell you if you can drive or use machines.

Lidocaine B. Braun contains sodium

This medicine contains less than 23 mg (1 mmol) of sodium per ampoule; this is essentially "sodium-free".

.

3. How to use Lidocaine B. Braun

Anesthetic therapy

Lidocaine B. Braun will be administered to you by a doctor. It will be given as an injection into a vein, into a muscle, under the skin, around the nerves, or into the epidural space near the spinal cord.

Lidocaine B. Braun will usually be administered near the part of the body that is to be operated on.

The dose that your doctor administers will depend on the type of pain relief you need. It will also depend on your height, age, and physical condition, as well as the part of the body where the medicine is injected. You will receive the lowest possible dose to produce the desired effect. The dose of lidocaine should be reduced in special populations and in patients in poor general condition.

Control of rapid or abnormal heartbeats

This medicine will be administered only by healthcare personnel, and your doctor will determine the most suitable dose for you.

The usual loading dose for adults is 50 to 100 mg, or 1 to 1.5 mg/kg body weight as a direct intravenous injection, at a rate that should not exceed 25-50 mg per minute.

To maintain therapeutic plasma concentrations (1.5-5 µg/ml), lidocaine should be infused at a rate of 20 to 50 µg/kg/min (about 1-4 mg per minute).

The dose should be adjusted according to individual needs and therapeutic effect.

This applies especially when there are heart, liver, or kidney problems.

During pregnancy, the dose should be as low as possible.

Use in children

Anesthetic therapy

The dose should be reduced in children. Lidocaine should be used with caution in children under four years of age.

The usual maximum dose is 400 mg or approximately 20 ml of Lidocaine B. Braun.

Control of rapid or abnormal heartbeats

The use of lidocaine is not recommended in newborns. The initial dose of lidocaine in children is 0.5 to 1 mg/kg. This dose may be repeated according to the patient's response, but the total dose should not exceed 3-5 mg/kg body weight. If maintenance is necessary, an intravenous infusion of 10 to 50 µg/kg/min can be administered using an infusion pump.

If you use more Lidocaine B. Braun than you should

The doctor treating you is prepared to treat serious side effects related to an overdose of Lidocaine B. Braun.

The first signs that you are using more lidocaine than you should are usually the following:

  • seizures,
  • restlessness,
  • feeling of tiredness or dizziness,
  • nausea,
  • numbness or tingling sensation of the lips and around the mouth,
  • vision problems.

If you experience any of these signs or if you think you have received more lidocaine than you should, tell your doctor or nurse immediately.

More serious side effects related to an overdose of lidocaine may occur, such as balance and coordination disorders, auditory changes, euphoria, confusion, speech problems, paleness, sweating, tremors, seizures, effects on the heart and blood vessels, loss of consciousness, coma, and short-term interruption of breathing (apnea).

If you have any further questions on the use of this product, ask your doctor.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service phone: 91.562 04 20, indicating the medicine and the amount used. Carry this leaflet with you.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor or nurse immediately if you experience a severe allergic reaction (angioedema or anaphylactic shock). The signs may include:

  • Sudden swelling of the face, lips, tongue, or throat; may lead to difficulty swallowing.
  • Severe or sudden swelling of the hands, feet, and ankles.
  • Difficulty breathing.
  • Severe itching of the skin (with hives).
  • Fever.
  • Low blood pressure.

The possible side effects after administration are essentially the same as those produced by other local anesthetics of the amide type.

Very common side effects (may affect more than 1 in 10 patients):

  • Nausea and vomiting.
  • Difficulty swallowing.
  • Depressed mood.

Common side effects (may affect up to 1 in 10 patients):

  • Transient neurological symptoms (pain in the legs and buttocks).
  • Confusion, restlessness, irritability, euphoria, hallucinations, and depression.
  • Drowsiness.
  • Dizziness.
  • Blurred vision.
  • Tremors.
  • Dizziness.
  • Tingling sensation.

Uncommon side effects (may affect up to 1 in 100 patients):

  • Seizures.
  • Numbness of the tongue or tingling sensation around the mouth.
  • "Noises" in the ears or sensitivity to noise.
  • Loss of consciousness.
  • Tinnitus.
  • Speech difficulties.
  • Hypertension (high blood pressure).

Rare side effects (may affect up to 1 in 1,000 patients):

  • Hypersensitivity reactions, such as urticaria, skin rash, angioedema, bronchospasm, difficulty breathing, and, in severe cases, anaphylactic shock.
  • Trauma.
  • Chills.
  • Irritation (reaction in a body area).
  • Spinal cord compression.
  • Muscle spasms.
  • Hypotension (low blood pressure).
  • Respiratory depression (slow or interrupted breathing).
  • Bradycardia (slow heart rate).

Very rare side effects (may affect up to 1 in 10,000 patients)

  • Ventricular tachycardia.

Side effects with unknown frequency (cannot be estimated from the available data)

  • Horner's syndrome (associated with epidural anesthesia or applications in the head and neck region).

Control of rapid or abnormal heartbeats

The following side effects can be serious. If you experience any of the following side effects, tell your doctor immediately. You may need immediate treatment.

Rare side effects (may affect up to 1 in 10,000 patients):

  • Allergic reactions ranging from rashes and swelling to severe allergic reactions such as low blood pressure, difficulty breathing, constriction of the airways, and anaphylactic shock.
  • Muscle contractions up to generalized seizures and convulsions.
  • Depression of the level of consciousness up to coma.
  • Slow heartbeats, heart block, and up to cardiac arrest.
  • Low blood pressure.
  • Difficulty breathing up to interruption of breathing.

Very rare (may affect up to 1 in 10,000 patients):

  • Rapid heartbeats.

Other side effects include:

very common (may affect more than 1 in 10 patients):

  • Feeling unwell, vomiting.
  • Anxiety, difficulty swallowing.

Common side effects (may affect up to 1 in 100 patients):

  • Confusion, restlessness, irritability, euphoria, hallucinations, depression.
  • Drowsiness, dizziness, sensation of spinning, difficulty speaking, tinnitus, blurred vision.
  • Sensation of tingling, numbness, burning, pinching, or numbness of the skin.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that the side effects are not listed in this leaflet. You can also report side effects directly through the Medicines Surveillance System www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Lidocaine B. Braun

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging. The expiry date is the last day of the month stated.

No special storage conditions are required.

For single use only. The contents of the ampoules should be used immediately after opening. Once the packaging is opened, discard the unused portion of the solution.

The solution should only be used if it is clear and colorless and the packaging is not damaged.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

Composition of Lidocaine B. Braun

The active substance is lidocaine hydrochloride.

1 ml of the solution for injection contains 20 mg of lidocaine hydrochloride.

Each 5 ml ampoule of solution contains 100 mg of lidocaine hydrochloride.

Each 10 ml ampoule of solution contains 200 mg of lidocaine hydrochloride.

The other ingredients are: sodium chloride, sodium hydroxide (for pH adjustment), and water for injections.

Appearance of the product and packaging contents

Lidocaine B. Braun is a clear and colorless solution for injection.

It is presented in polyethylene (Mini-Plasco) ampoules of 5 and 10 ml. It is presented in packs of 1, 20, and 100 ampoules.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

  • Braun Medical, S.A.

Ctra. de Terrassa, 121

08191-Rubí (Barcelona)

Spain

Manufacturer

  • Braun Medical, S.A.

Ctra. de Terrassa, 121

08191-Rubí (Barcelona)

  • Braun Melsungen AG

Carl-Braun-Strasse 1 Postal address:

34212 Melsungen, Germany 34209 Melsungen, Germany

Date of last revision of this leaflet:June 2021.

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products. http//www.aemps.gob.es/

-------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Dosage and Administration

Lidocaína B. Braun should only be used by physicians with experience in regional anesthesia and resuscitation techniques or under their supervision. Resuscitation equipment should be available when administering local anesthetics. The lowest possible dose that produces the desired effect should be administered. The dose must be adjusted individually according to the specific characteristics of each case.

Anesthetic Treatment

Adults

When injected into tissues with high systemic absorption, the single dose of lidocaine hydrochloride should not exceed 400 mg. The table described below can serve as a guide for adults with a body weight of approximately 70 kilograms. The dose should be adjusted based on age, weight, and patient condition:

Route of administration or procedure

Recommended doses of lidocaine hydrochloride

Concentration (mg/ml)

Volume (ml)

Total dose (mg)

Infiltration anesthesia

Minor procedures

10 mg/ml

2-10 ml

20-100 mg

Major procedures

10 mg/ml

20 mg/ml

10-20 ml

5-10 ml

100-200 mg

100-200 mg

Intravenous regional anesthesia:

Arm

10 mg/ml

20 mg/ml

10-20 ml

5-10 ml

100-200 mg

100-200 mg

Leg

10 mg/ml

20 mg/ml

20 ml

10 ml

200 mg

200 mg

Nerve blocks

10 mg/ml

20 mg/ml

2-20 ml

1-10 ml

20-200 mg

20-200 mg

Epidural anesthesia:

Lumbar analgesia

10 mg/ml

20 mg/ml

25-40 ml

12.5-20 ml

250-400 mg

250-400 mg

Thoracic anesthesia

10 mg/ml

20 mg/ml

20-30 ml

10-15 ml

200-300 mg

200-300 mg

Surgical sacral analgesia

10 mg/ml

20 mg/ml

40 ml

20 ml

400 mg

400 mg

Obstetric sacral analgesia

10 mg/ml

20 mg/ml

20-30 ml

10-15 ml

200-300 mg

200-300 mg

To prolong anesthesia, lidocaine may be combined with a vasoconstrictor, such as adrenaline. The addition of adrenaline at a concentration of 1/100,000 to 1/200,000 has been effective.

Special Populations

In patients with renal or hepatic insufficiency and in elderly patients, the dose should be reduced according to the patient's age and physical condition (see sections 4.4 and 5.2 of the technical sheet).

Pediatric Population

The doses are calculated individually according to the patient's age and body weight and the nature of the procedure. The anesthesia technique should be carefully selected, and those techniques that are painful should be avoided. The child's behavior should be closely monitored during treatment. The average dose to be administered is in the range of 20 mg to 30 mg of lidocaine hydrochloride per session. The dose of lidocaine hydrochloride that can be administered to children can also be calculated using the expression: child's weight (in kilograms) x 1.33.

The equivalent of 5 mg of lidocaine hydrochloride per kilogram of body weight should not be exceeded.

To prevent systemic toxicity in children, the lowest effective concentration should always be used.

Lidocaine is indicated in adults and children. However, it should be used with caution in children under four years of age, as there is limited data to support the safety and efficacy of this product in this patient population at this time.

Lidocaine injectable is not recommended for use in newborns (see section 5.2 of the technical sheet). In this age group, the optimal concentration of lidocaine in serum necessary to avoid toxic effects such as convulsions and cardiac arrhythmias is unknown.

Treatment of Severe Ventricular Arrhythmias

Lidocaine is generally administered in cases of severe ventricular arrhythmias that do not respond to other antiarrhythmics such as beta blockers or amiodarone or in cases of contraindications for amiodarone.

The dose should be adjusted individually according to the needs of each patient and the clinical response obtained.

Adults

Loading dose (intravenous bolus):

The usual loading dose is 50 to 100 mg or 1 to 1.5 mg/kg of body weight as a direct intravenous injection, corresponding to 2.5 – 5 ml or 0.05 – 0.075 ml/kg of Lidocaine B. Braun 20 mg/ml.

The injection rate should not exceed 25-50 mg/min, corresponding to 1.25 – 2.5 ml/min of Lidocaine B. Braun 20 mg/ml.

If the therapeutic effect after the first dose is insufficient during the first 5-10 minutes, a second dose of 0.5 to 0.75 mg/kg should be administered once or twice, up to a maximum of 200-300 mg in 1 hour.

Maintenance dose (intravenous infusion):

To maintain therapeutic plasma concentrations (1.5 - 5 µg/ml), lidocaine should be infused at a rate of 20 - 50 µg/kg/min (over 1-4 mg/min), corresponding to 0.001 – 0.0025 ml /kg /min of Lidocaine B. Braun 20 mg/ml.

The infusion should be stopped as soon as the patient's heart rate is apparently stable or at the first signs of toxicity. It is rarely necessary to continue the infusion after 24 hours. A reduction in dose may be necessary in prolonged intravenous infusions (over 24 hours) due to the risk of accumulation. As soon as possible, patients should be switched to oral antiarrhythmic maintenance therapy.

Special Populations

Use in Elderly Patients

In elderly patients, the dose should be calculated individually according to the patient's age and body weight. A reduction in dose may be necessary in this population, as cardiac output and hepatic blood flow decrease with age, resulting in a decrease in lidocaine elimination (see section 5.2 of the technical sheet).

Cardiac and Hepatic Insufficiency

The dose should be reduced in patients with cardiac and hepatic insufficiency due to a reduction in lidocaine clearance (see section 5.2 of the technical sheet).

Renal Insufficiency

Renal insufficiency generally does not require special dose adjustment. However, these patients should be monitored for toxic effects caused by the accumulation of metabolites. In cases of severe renal insufficiency, dose adjustment may be necessary (see section 5.2 of the technical sheet).

Pediatric Population

The safety and efficacy of lidocaine use in children have not been fully established. Lidocaine is not recommended for use in newborns (see section 5.2 of the technical sheet).

The initial dose of lidocaine in children is 0.5- 1 mg/kg. This dose may be repeated according to the patient's response, but the total dose should not exceed 3-5 mg/kg of body weight. If maintenance is necessary, an intravenous infusion of 10 - 50 µg/kg/min can be administered using an infusion pump.

For advanced cardiovascular life support in children, a rapid intravenous or intraosseous (bolus) dose of 1 mg/kg of body weight up to a maximum dose of 100 mg is recommended.

If ventricular tachycardia or ventricular fibrillation is not corrected by defibrillation (or cardioversion) and the recommended initial dose of lidocaine, an intravenous or intraosseous infusion at a rate of 20-50 µg/kg of body weight per minute should be administered.

Administration

Anesthetic Therapy

The administration of lidocaine varies depending on the anesthesia procedure used (infiltration anesthesia, intravenous regional anesthesia, nerve block, or epidural anesthesia).

Lidocaine B. Braun can be administered intramuscularly, subcutaneously, intradermally, perineurally, epidurally, or intravenously (in local intravenous anesthesia or Bier block).

Treatment of Severe Ventricular Arrhythmias

Intravenously. Intraosseously.

Administer as a slow intravenous injection or as an intravenous infusion after dilution with a suitable solution (see sections 6.2 and 6.6 of the technical sheet).

Due to the relatively short duration of action of lidocaine, the injection should be followed by a continuous infusion, if possible, using an infusion pump. Continuous monitoring of the ECG, blood pressure, level of consciousness, and respiration (see section 4.4 of the technical sheet) is recommended during the administration of lidocaine.

The infusion solution can be prepared by adding 1000 mg of lidocaine hydrochloride, corresponding to 50 ml of Lidocaine B. Braun 20 mg/ml, to a volume of 500 ml of glucose or saline solution, resulting in a concentration of 2 mg/ml.

Interactions with Other Medicinal Products and Other Forms of Interaction

Drugs that inhibit the metabolism of lidocaine (e.g., cimetidine) may cause potentially toxic plasma concentrations when lidocaine is administered repeatedly in high doses over prolonged periods. Such interactions are of no clinical relevance during short-term treatment with lidocaine at the recommended doses.

Lidocaine should be used with caution in patients receiving other local anesthetics or antiarrhythmic drugs of class Ib, as toxic effects are cumulative.

No specific interaction studies have been conducted with lidocaine and antiarrhythmic drugs of class III (e.g., amiodarone), but caution is recommended (see section 4.4 of the technical sheet).

If lidocaine is administered as an antiarrhythmic agent, additional medication with epinephrine or norepinephrine may potentiate adverse cardiac effects.

Class I Antiarrhythmic Agents

The simultaneous administration of lidocaine with other class I antiarrhythmic agents should be avoided, as there is a risk of severe cardiac adverse effects.

Other Antiarrhythmic Agents

If lidocaine is used in combination with other antiarrhythmic agents such as beta blockers or calcium channel blockers, the inhibitory effect on atrioventricular and intraventricular conduction and contractility may be increased.

Drugs that May Decrease the Seizure Threshold

Since lidocaine itself decreases the seizure threshold, co-administration with other drugs that decrease the seizure threshold (e.g., tramadol or bupropion) may increase the risk of seizures.

Special Warnings and Precautions for Use

In general, before injecting lidocaine, it should be ensured that all emergency resuscitation equipment and medications for the treatment of toxic reactions are available. In cases of major blocks, an intravenous cannula should be inserted before injecting the local anesthetic. Like all local anesthetics, lidocaine can cause acute toxic effects on the cardiovascular and central nervous systems when high blood concentrations occur, especially after extensive intravascular administration.

Caution should be exercised in the treatment of the following categories of patients:

  • Elderly and debilitated patients in general.
  • Patients with AV block II or III, as the local anesthetic can reduce myocardial conductivity.
  • Patients with congestive heart failure, bradycardia, or impaired respiratory function.
  • Patients with severe hepatic or renal disease.
  • Patients with epilepsy. These patients should be carefully monitored for the appearance of central nervous system symptoms. An increase in the tendency to seizures should be considered even with doses below the maximum.
  • Patients with coagulopathy. Treatment with anticoagulants (e.g., heparin), NSAIDs, or plasma substitutes increases the tendency to bleeding. Accidental injury to blood vessels can cause severe bleeding. If necessary, bleeding time and partial thromboplastin time (PTT) should be checked, as well as platelet count.
  • Third trimester of pregnancy
  • In children under four years of age, as safety and efficacy data are limited
  • In newborns, special caution should be exercised (see section 5.2 of the technical sheet)

Patients treated with class III antiarrhythmic drugs (e.g., amiodarone) should be closely monitored, and ECG monitoring should be considered, as the cardiac effects of lidocaine and class III antiarrhythmic drugs may be cumulative (see section 4.5 of the technical sheet).

There have been post-marketing reports of cases of chondrolysis in patients who received continuous postoperative intra-articular infusion of local anesthetics. In most of the reported cases of chondrolysis, the shoulder joint was involved. Due to the multiple contributing factors and the inconsistency in the scientific literature regarding the mechanism of action, causality has not been established. Continuous intra-articular infusion is not an approved indication for lidocaine (see section 4.8 of the technical sheet).

Epidural anesthesia can cause serious adverse effects such as cardiovascular depression, especially in cases of concomitant hypovolemia. Caution should always be exercised in patients with reduced cardiovascular function.

Epidural anesthesia can cause hypotension and bradycardia. This risk can be reduced by administering intravenous crystalloid or colloid solutions. Hypotension should be treated immediately with, for example, ephedrine 5-10 mg intravenously; repeat as necessary.

Paracervical block can occasionally cause fetal bradycardia or tachycardia, and close monitoring of fetal heart rate is necessary (see section 4.6 of the technical sheet).

Neurological trauma and/or local toxic effects on muscles and nerves are mainly caused by the injection of local anesthetics. The extent of these tissue lesions depends on the magnitude of the trauma, the concentration of the local anesthetic, and the duration of tissue exposure to the local anesthetic. For this reason, the minimum effective dose should be used.

Special caution should also be exercised when injecting the local anesthetic into inflamed (infected) tissue due to increased systemic absorption caused by increased blood flow and decreased effect due to the lower pH of infected tissue.

After removing the tourniquet after intravenous regional anesthesia, there is a greater risk of adverse reactions. Therefore, the local anesthetic should be eliminated in several fractions.

During anesthetic procedures in the neck and head region, patients are exposed to a higher risk of toxic effects of the drug on the central nervous system even at low doses (see section 4.8 of the technical sheet).

Rarely, retro-ocular injections can reach the subarachnoid cranial space, causing intense/severe reactions, including cardiovascular collapse, apnea, convulsions, and transient blindness.

Retro- and periocular injections of local anesthetics carry a low risk of persistent ocular motor dysfunction. The main causes include trauma and/or local toxic effects on muscles and/or nerves.

Intramuscular lidocaine can increase creatine phosphokinase levels, which can interfere with the diagnosis of acute myocardial infarction.

Lidocaine injectable is not recommended for use in newborns (see section 5.2 of the technical sheet).

Lidocaine has been shown to be porphyrinogenic in animals and should not be administered to patients with acute porphyria unless absolutely unavoidable. Precautions should be taken in all patients with porphyria.

Antiarrhythmic Therapy

In acidosis, the binding of lidocaine to plasma proteins is reduced, and therefore, the concentration of free lidocaine is increased. Therefore, the effect of lidocaine may be intensified in cases of acidosis.

Hypokalemia, hypoxia, and acid-base balance disorders should be corrected before using lidocaine in patients who require large doses of antiarrhythmic agents.

During prolonged parenteral therapy with lidocaine, fluid balance, serum electrolytes, and acid-base balance should be regularly monitored.

The administration of lidocaine should be accompanied by continuous monitoring of the ECG, blood pressure, level of consciousness, and respiration. Especially, the adjustment of the dose of antiarrhythmic drugs requires careful monitoring. Cardiac emergency equipment should be available. If one or more of the parameters indicate a worsening of cardiac function, a therapeutic review should be performed, which may include the discontinuation of lidocaine if necessary.

Note: In sedated patients, central nervous system disorders may go unnoticed, and cardiac adverse effects may occur without other warning symptoms.

Online doctors for LIDOCAINE B. BRAUN 20 mg/ml injectable solution

Discuss questions about LIDOCAINE B. BRAUN 20 mg/ml injectable solution, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

LIDOCAINE B. BRAUN 20 mg/ml injectable solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in LIDOCAINE B. BRAUN 20 mg/ml injectable solution is lidocaine. This information helps identify medicines with the same composition but different brand names.

The average pharmacy price for LIDOCAINE B. BRAUN 20 mg/ml injectable solution is around 1 EUR. Prices may vary depending on the manufacturer and dosage form.

LIDOCAINE B. BRAUN 20 mg/ml injectable solution is manufactured by B Braun Medical S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Psychiatrists, Neurologists, General medicine doctors, Pain medicine doctors, Anaesthesiologists may assess whether LIDOCAINE B. BRAUN 20 mg/ml injectable solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, LIDOCAINE B. BRAUN 20 mg/ml injectable solution is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (lidocaine) include ACTILOGIC 700 MG MEDICATED ADHESIVE DRESSING, DYNEXAN 20 mg/g BUCAL GEL, INSTILLIDO 20 mg/ml GEL. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media